Standardized RS Ratio Metrics To Assess Tuberculosis Antimicrobial Efficacy and Potency
- PMID: 36622159
- PMCID: PMC9872615
- DOI: 10.1128/aac.01483-22
Standardized RS Ratio Metrics To Assess Tuberculosis Antimicrobial Efficacy and Potency
Abstract
The sigmoid Emax model was used to describe the rRNA synthesis ratio (RS ratio) response of Mycobacterium tuberculosis to antimicrobial concentration. RS-Emax measures the maximal ability of a drug to inhibit the RS ratio and can be used to rank-order drugs based on their RS ratio effect. RS-EC90 is the concentration needed to achieve 90% of the RS-Emax, which may guide dose selection to achieve a maximal RS ratio effect in vivo.
Keywords: Mycobacterium tuberculosis; RS ratio; antibiotic; antimicrobial; drug effects; drug therapy; precursor rRNA.
Conflict of interest statement
The authors declare a conflict of interest. M.I.V., G.T.R., N.D.W. are listed as inventors on patent #U.S. Patent No. 16/632,310 for “Methods Of Evaluating Treatment Efficacy and/or Treatment Duration In Mycobacterial Diseases.”
Figures

References
-
- Nahid P, Saukkonen J, Mac Kenzie WR, Johnson JL, Phillips PPJ, Andersen J, Bliven-Sizemore E, Belisle JT, Boom WH, Luetkemeyer A, Campbell TB, Eisenach KD, Hafner R, Lennox JL, Makhene M, Swindells S, Villarino ME, Weiner M, Benson C, Burman W, Centers for Disease Control and Prevention . 2011. Tuberculosis biomarker and surrogate endpoint research roadmap. Am J Respir Crit Care Med 184:972–979. doi:10.1164/rccm.201105-0827WS. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical